FDA’s Evisceration of the Labeling Exemption in 21 USC 343-2
The FDA has rendered the labeling exemption in 21 USC 343-2 a dead letter through construction. That provision of the Dietary Supplement Health and Education Act was inartfully written but nevertheless designed by Congress to liberate dietary supplement companies from the prohibition on nutrient-disease claims in 21 USC 343 when they supplied independent scientific literature […]